Logo
 
USD 916.42  CAD 1203.57  EUR 857.89  AUD 1214.48  GBP 730.94 
 

Browse Categories

Search Options

Search terms:

Listing type:

All  Fixed Price  Auction

Product type:

All  Digital  Physical

Price range:

USD  to USD

Origin country:

Ships to:

Order by:

Active vendor:

Automatic fulfillment:

Multisig options:

Bulk discounts:

In stock:

Payment type:

Cryptocurrency:

Average vendor processing:

Vendor trust level:

to

Exchange Rates

Bitcoin (BTC)

United States Dollar (USD)
916.42
 
Canadian Dollar (CAD)
1,203.57
 
Euro (EUR)
857.89
 
Australian Dollar (AUD)
1,214.48
 
British Pound (GBP)
730.94
 
Deposits & Withdrawals
 

Monero (XMR)

United States Dollar (USD)
11.71
 
Canadian Dollar (CAD)
15.38
 
Euro (EUR)
10.96
 
Australian Dollar (AUD)
15.52
 
British Pound (GBP)
9.34
 
Deposits & Withdrawals
 

The above rates are updated every 10 minutes and taken using a weighted average of major exchange platforms.

 

PT-141 - Bremelanotide - Bio-Peptide

Potency: 10mg; Carton Size: box Read all Terms in my profile before ordering! Bremelanotide PT-141, or bremelanotide, belongs to the new class of synthetic proteins that work as melanocortin agonists. It is a peptidic compound under new drug development process known as palatin technology. Its molecular formula is C50H68N14O10; its molecular weight/mass is 1025.2. This new representati...

Sold by Rxtream - 1 sold since Mar 31, 2016  Vendor Level 1 Trust Level 5

 
Features
 
Product class
Physical package
 
Quantity left
Unlimited
 
Ends in
Never
 
 
Features
 
Origin country
Poland
 
Ships to
Worldwide
 
Payment
Escrow
 
 

Purchase price: USD 56.96

Qty:  
0.0622 BTC / 4.8642 XMR

 

Product Description

Potency: 10mg; Carton Size: box
Read all Terms in my profile before ordering!

Bremelanotide

PT-141, or bremelanotide, belongs to the new class of synthetic proteins that work as melanocortin agonists. It is a peptidic compound under new drug development process known as palatin technology. Its molecular formula is C50H68N14O10; its molecular weight/mass is 1025.2.


This new representative of peptides was synthesized just recently from melanotan-ppeptide, and till now is being participating in few clinical trials with animal models in different countries. To date, the biggest randomized controlled and double-blind clinical studies were done in 2004 and 2007 with looking at safety evaluation, pharmacokinetic features and its pharmacodynamics for males and females respectively. In the end of 2012 the second phase of clinical trial was finished and its results will be published soon.
PT-141's primary feature is to have positive influence to sexual systemic dysfunction. Unlike other compounds and hormones bremelanotide doesn't affect the vascular system; instead this research compound works by stimulating melanocortin receptors, and that in turn leads to sexual stimulation and to modulation of inflammation.

Anastrozol Letrozol Exemestan GH HGH Growth Hormone 176-191 Peptide IGF Insulin Like Growth Factor Long R3